BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 19036682)

  • 61. [PET/CT with (18F)FDG in the initial staging of a pelvic kidney neoplasm. A case report].
    Pifarré Montaner P; Simó Perdigó M; Plaza López P; Marco V; Alvarez Castells A; Martínez-Miralles E
    Rev Esp Med Nucl; 2009; 28(4):200-3. PubMed ID: 19922833
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Interpretation, accuracy and management implications of FDG PET/CT in cutaneous malignant melanoma.
    Falk MS; Truitt AK; Coakley FV; Kashani-Sabet M; Hawkins RA; Franc B
    Nucl Med Commun; 2007 Apr; 28(4):273-80. PubMed ID: 17325590
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].
    Xu HF; Liu Y; Zhang JH; Zhou RS; Zhou FH; Yuan MH
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):108-11. PubMed ID: 15854393
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Routine FDG PET-CT in patients with a high-risk localized melanoma has a high predictive positive value for nodal disease and high negative predictive value for the presence of distant metastases.
    Wagner T; Chevreau C; Meyer N; Mourey L; Courbon F; Zerdoud S
    J Eur Acad Dermatol Venereol; 2012 Nov; 26(11):1431-5. PubMed ID: 22017492
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Improved staging with pretreatment positron emission tomography/computed tomography in low rectal cancer.
    Gearhart SL; Frassica D; Rosen R; Choti M; Schulick R; Wahl R
    Ann Surg Oncol; 2006 Mar; 13(3):397-404. PubMed ID: 16485158
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of silent metastases from malignant melanoma.
    Eigtved A; Andersson AP; Dahlstrøm K; Rabøl A; Jensen M; Holm S; Sørensen SS; Drzewiecki KT; Højgaard L; Friberg L
    Eur J Nucl Med; 2000 Jan; 27(1):70-5. PubMed ID: 10654150
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Assessing response to chemotherapy in metastatic melanoma with FDG PET: Early experience.
    Hofman MS; Constantinidou A; Acland K; Healy C; Harries M; O'Doherty M;
    Nucl Med Commun; 2007 Dec; 28(12):902-6. PubMed ID: 18090215
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures.
    Fuster D; Duch J; Paredes P; Velasco M; Muñoz M; Santamaría G; Fontanillas M; Pons F
    J Clin Oncol; 2008 Oct; 26(29):4746-51. PubMed ID: 18695254
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Use of Preoperative PET/CT Staging in Sentinel Lymph Node-Positive Melanoma.
    Scheier BY; Lao CD; Kidwell KM; Redman BG
    JAMA Oncol; 2016 Jan; 2(1):136-7. PubMed ID: 26401901
    [No Abstract]   [Full Text] [Related]  

  • 71. Value of tumour marker S-100B in melanoma patients: a comparison to 18F-FDG PET and clinical data.
    Reinhardt MJ; Kensy J; Frohmann JP; Willkomm P; Reinhold U; Grünwald F; Biersack HJ; Bender H
    Nuklearmedizin; 2002 Jun; 41(3):143-7. PubMed ID: 12109034
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
    Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography.
    Chen J; Cheong JH; Yun MJ; Kim J; Lim JS; Hyung WJ; Noh SH
    Cancer; 2005 Jun; 103(11):2383-90. PubMed ID: 15856477
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Outcome of clinical stage III melanoma patients with FDG-PET and whole-body CT added to the diagnostic workup.
    Niebling MG; Bastiaannet E; Hoekstra OS; Bonenkamp JJ; Koelemij R; Hoekstra HJ
    Ann Surg Oncol; 2013 Sep; 20(9):3098-105. PubMed ID: 23612885
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant: a prospective study.
    Tournoy KG; Maddens S; Gosselin R; Van Maele G; van Meerbeeck JP; Kelles A
    Thorax; 2007 Aug; 62(8):696-701. PubMed ID: 17687098
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Whole body positron emission tomography/computed tomography staging of metastatic choroidal melanoma.
    Kurli M; Reddy S; Tena LB; Pavlick AC; Finger PT
    Am J Ophthalmol; 2005 Aug; 140(2):193-9. PubMed ID: 15992753
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Is 18F-FDG PET more accurate than standard diagnostic procedures in the detection of suspected recurrent melanoma?
    Fuster D; Chiang S; Johnson G; Schuchter LM; Zhuang H; Alavi A
    J Nucl Med; 2004 Aug; 45(8):1323-7. PubMed ID: 15299056
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Improved detection of second primary cancer using integrated [18F] fluorodeoxyglucose positron emission tomography and computed tomography for initial tumor staging.
    Choi JY; Lee KS; Kwon OJ; Shim YM; Baek CH; Park K; Lee KH; Kim BT
    J Clin Oncol; 2005 Oct; 23(30):7654-9. PubMed ID: 16234527
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Assessment of pulmonary melanoma metastases with 18F-FDG PET/CT: which PET-negative patients require additional tests for definitive staging?
    Mayerhoefer ME; Prosch H; Herold CJ; Weber M; Karanikas G
    Eur Radiol; 2012 Nov; 22(11):2451-7. PubMed ID: 22653282
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clinical role of (18)F-FDG PET for initial staging of patients with extrahepatic bile duct cancer.
    Kato T; Tsukamoto E; Kuge Y; Katoh C; Nambu T; Nobuta A; Kondo S; Asaka M; Tamaki N
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1047-54. PubMed ID: 12173019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.